By InvitationNot Applicable

Mechanical Thrombectomy in the Middle East and North Africa: Interim Results from the MEMENTO Registry

Egypt1,500 participantsStarted 2022-03-11

Plain-language summary

The MEMENTO (MEchanical thrMobectomy NETwork for MENA TOgether) Registry is a multicenter, prospective observational study aiming to evaluate the effectiveness, safety, and cost-effectiveness of mechanical thrombectomy (MT) in patients with acute ischemic stroke (AIS) due to large vessel occlusions (LVO) in the Middle East and North Africa (MENA) region. This interim analysis reports on the first 499 patients enrolled, assessing clinical outcomes, procedural details, and economic implications.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Adults aged 18 years and older (no upper age limit). Diagnosed with acute ischemic stroke due to confirmed large vessel occlusion (LVO) or medium vessel occlusion (MeVO). Underwent mechanical thrombectomy (MT) with or without prior intravenous thrombolysis (IV tPA). Pre-stroke modified Rankin Scale (mRS) score of 0-5. Consent to participate in the registry (by patient or legal representative). Exclusion Criteria: Absence of confirmed LVO or MeVO. Pre-stroke mRS score of 6. Known severe comorbid conditions precluding MT. Inability to obtain informed consent. Patients not treated with MT.

What they're measuring

Functional Independence at 90 Days

Timeframe: 90 days post-procedure

Trial details

NCT IDNCT06702787

SponsorMiddle East North Africa Stroke and Interventional Neurotherapies Organization

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-04-11

View on ClinicalTrials.gov More Stroke trials